Company / Return on Assets (ROA)
AGIOS PHARMACEUTICALS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-31.8%
FY2025
5-year range
-37.6% / 40.5%
FY2021-FY2025
Trend
-178.5%
vs FY2024
Sector context
#138 of 213
Health Care
What the data says
At -31.8%, AGIOS PHARMACEUTICALS, INC.'s return on assets (roa) ranks #138 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -51.2% in FY2017 to 40.5% in FY2024.
Based on SEC 10-K filings.
-31.8% in FY2025 with a 5-year CAGR of +8.8%.
Improved from -37.6% to -31.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -5.4pp
- 5-Year Change
- +8.8pp
- 10-Year Change
- -
Sector benchmark
#138 of 213 in Health CareTop 65% of 213This company -31.8% Sector average -24.2%
▼
-31.7% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 178.5% year-over-year.
- Currently 7.7pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -31.8% | -178.5% |
| FY2024 | 40.5% | +207.8% |
| FY2023 | -37.6% | -42.1% |
| FY2022 | -26.4% | - |
| FY2021 | - | - |
| FY2020 | -40.6% | +12.2% |
| FY2019 | -46.2% | -99.8% |
| FY2018 | -23.1% | +54.9% |
| FY2017 | -51.2% | -59.8% |
| FY2016 | -32.1% | -241.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026